Remove FDA Remove Immunization Remove Independent Pharmacies
article thumbnail

FDA Approves Nitisinone for Treatment of Alkaptonuria

Drug Topics

The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in patients with alkaptonuria (AKU). The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in patients with alkaptonuria (AKU). The medication is expected to launch in July 2025.

FDA 341
article thumbnail

State-Level PBM Reform Vital for Community Pharmacies, Patient Access

Drug Topics

READ MORE: Q&A: Retail, Independent Pharmacies Continue to Call for Improved Reimbursement Practices Don’t get left behind: Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips delivered straight to your inbox.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Widaplik for Treatment of Hypertension

Drug Topics

The FDA approved telmisartan, amlodipine and indapamide (Widaplik) for the treatment of hypertension in adult patients, George Medicines said in a release. The FDA approved telmisartan, amlodipine and indapamide (Widaplik) for the treatment of hypertension in adult patients, George Medicines said in a release.

FDA 281
article thumbnail

Q&A: Pharmacist Highlights Challenges in Vaccine Information Navigation Amid Changing Recommendations

Drug Topics

She highlighted the challenges of maintaining accurate, transparent vaccine guidance, focusing on the importance of trusted health care providers helping patients understand immunization strategies. This schedule also helped dictate insurance coverage of those recommended vaccines.

Vaccines 520
article thumbnail

Elevating Pharmacy Technicians in Community Practice

Drug Topics

Recognition matters—whether it’s posting their certifications, assigning leadership roles like inventory or immunization coordination, or simply trusting them with responsibilities they already handle. Pharmacists can also advocate for them by acknowledging unfair pay or treatment and being transparent about efforts to improve conditions.

article thumbnail

Meeting Preview: McKesson ideaShare 2025

Drug Topics

The sessions this year range from business sessions, including topics on product placement, advocacy, and inventory management, to educational sessions, including diabetes, immunizations, and hormonal contraceptive services. The Drug Topics team will be onsite at the meeting providing coverage of all the most important happenings.

article thumbnail

Once Monthly Oral PrEP Medication Will Advance to Phase 3 Study

Drug Topics

Recent Videos Related Content FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1 Killian Meara July 10th 2025 Article The FDA set a Prescription Drug User Fee Act (PDUFA) date of April 28, 2026. Subscribe Now!